Status:
COMPLETED
Hyperhydrosis Treatment Using Botulinum Toxin
Lead Sponsor:
St Joseph University, Beirut, Lebanon
Conditions:
Hyperhidrosis
Eligibility:
MALE
18-90 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to describe two safe and reproducible techniques for the treatment of hyperhidrosis using botulinum toxin. The same patient will receive two different injection technique ...
Detailed Description
The abobotulinumtoxinA (ABO) will be used in all patients. The ABO will be prepared by adding 4 cc of normal saline to a 500-unit Dysport© (Ipsen Ltd, Berks, UK) vial Preinjection patient pictures wil...
Eligibility Criteria
Inclusion
- Consecutive 15 male patients presenting to our clinic for primary localized hyperhidrosis will be included in this study
Exclusion
- Patient that has received a botulinum injection in the past year
- Patient that had a liposuction in the armpit or laser for the hair
- Patients with preexisting neuromuscular conditions (myasthenia gravis, Eaton Lambert syndrome) Patients using medication that could potentiate the effect of botulinum (ex: aminoglycoside antibiotics) Patients with sensitivity to botulinum toxin or human albumin
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2019
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03816046
Start Date
May 1 2018
End Date
January 1 2019
Last Update
January 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hotel Dieu de France
Beirut, Lebanon, 0000